JP2024544415A - 動物における呼吸器疾患の治療のための注射用医薬組成物 - Google Patents

動物における呼吸器疾患の治療のための注射用医薬組成物 Download PDF

Info

Publication number
JP2024544415A
JP2024544415A JP2024537407A JP2024537407A JP2024544415A JP 2024544415 A JP2024544415 A JP 2024544415A JP 2024537407 A JP2024537407 A JP 2024537407A JP 2024537407 A JP2024537407 A JP 2024537407A JP 2024544415 A JP2024544415 A JP 2024544415A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
injectable pharmaceutical
compound
formula
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024537407A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024544415A5 (https=
Inventor
ワン，チェン－チャオ
マイヤー，トルステン
ワラス，ラルフ
ウルリッヒ，ヨアヒム
Original Assignee
インターベット インターナショナル ベー． フェー．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インターベット インターナショナル ベー． フェー． filed Critical インターベット インターナショナル ベー． フェー．
Publication of JP2024544415A publication Critical patent/JP2024544415A/ja
Publication of JP2024544415A5 publication Critical patent/JP2024544415A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2024537407A 2021-12-24 2022-12-23 動物における呼吸器疾患の治療のための注射用医薬組成物 Pending JP2024544415A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21217704.2 2021-12-24
EP21217704 2021-12-24
PCT/EP2022/087700 WO2023118557A1 (en) 2021-12-24 2022-12-23 An injectable pharmaceutical composition for the treatment of respiratory diseases in animals

Publications (2)

Publication Number Publication Date
JP2024544415A true JP2024544415A (ja) 2024-11-29
JP2024544415A5 JP2024544415A5 (https=) 2026-01-05

Family

ID=79601675

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024537407A Pending JP2024544415A (ja) 2021-12-24 2022-12-23 動物における呼吸器疾患の治療のための注射用医薬組成物

Country Status (9)

Country Link
US (1) US20250057790A1 (https=)
EP (1) EP4452226A1 (https=)
JP (1) JP2024544415A (https=)
CN (1) CN118632684A (https=)
AR (1) AR128074A1 (https=)
AU (1) AU2022420882A1 (https=)
CA (1) CA3242451A1 (https=)
MX (1) MX2024007862A (https=)
WO (1) WO2023118557A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations
WO2025133098A2 (en) 2023-12-21 2025-06-26 Intervet International B.V. Processes to make crystalline forms of (s)-n-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4- ((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamide salts
WO2025133088A1 (en) 2023-12-21 2025-06-26 Intervet International B.V. Crystalline forms of(s)-n-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4- ((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamide salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740421A (en) 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
BR112019012861A2 (pt) 2016-12-23 2019-12-10 Intervet Int Bv compostos para o tratamento de doença respiratória bovina ou suína

Also Published As

Publication number Publication date
WO2023118557A1 (en) 2023-06-29
MX2024007862A (es) 2024-07-09
CN118632684A (zh) 2024-09-10
AR128074A1 (es) 2024-03-20
AU2022420882A1 (en) 2024-06-20
EP4452226A1 (en) 2024-10-30
CA3242451A1 (en) 2023-06-29
US20250057790A1 (en) 2025-02-20

Similar Documents

Publication Publication Date Title
JP2024544415A (ja) 動物における呼吸器疾患の治療のための注射用医薬組成物
JP4772324B2 (ja) ウシおよびブタにおける感染を処置するための組成物および方法
EP1626739B1 (en) Compositions comprising florfenicol or a structurally related compound for treating infection in cattle and swine
Stipkovits et al. The efficacy of valnemulin (Econor®) in the control of disease caused by experimental infection of calves with Mycoplasma bovis
JP2006528705A5 (https=)
MXPA06012303A (es) Uso de formulaciones de meloxicam en medicina veterinaria.
KR20040074999A (ko) 케토프로펜을 함유하는 음료 제제 및 동물군에서 열병,염증 및/또는 통증을 수반하는 질환의 동시 치료에서 이의용도
RU2197237C2 (ru) Способ лечения заболеваний животных, вызванных бактериями (варианты), и способ изготовления лекарственного средства
Dorrestein et al. Clinical pharmacology and pharmacokinetics of flumequine after intravenous, intramuscular and oral administration in pigeons (Columba livid)
BR0016262B1 (pt) Processo para produção de uma formulação para injeção não-aquosa de valnemulina
US20020068065A1 (en) Pharmaceutical composition having specific water activity
CN113476431A (zh) 一种环三酮衍生物在制备动物用药中的应用
Nagaraja Liver abscesses in beef cattle: potential for dairy monitoring?
KR20250106485A (ko) 동물의 피부 질환을 치료하기 위한 조성물
CN119158025A (zh) 一种用于治疗动物支原体感染的药物制剂及其应用
KR20210145045A (ko) 세균의 복합 감염에 의한 동물의 호흡기 질환 치료용 조성물
AU7570891A (en) Veterinary treatment of lambs and sheep

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251219

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251219